Phase IV Clinical Trial, Immunogenicity and Safety of EV71 Vaccine

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The purpose of this study is to evaluate the immunogenicity and safety of EV71 vaccine in infants aged 6 to 35 months old, by detecting the dynamic changes of neutralizing antibody at different time after vaccination
Epistemonikos ID: 654bf8e98e278ae3072292b3b60865120392258e
First added on: May 21, 2024